Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

Archives of Neurology

Volumn 61, Issue 6, 2004, Pages 914-918

  Barbano, Richard L ^a   Herrmann, David N ^a   Hart Gouleau, Stephanie ^a   Pennella Vaughan, Janet ^a   Lodewick, Peter A ^b   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Southern Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ARTICLE; BURNING SENSATION; DIABETIC NEUROPATHY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PHOTOSENSITIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; DIABETIC NEUROPATHIES; DOSAGE FORMS; HUMANS; LIDOCAINE; PAIN MEASUREMENT; QUALITY OF LIFE;

EID: 2942532905     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.6.914     Document Type: Article

References (11)

1. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-354.
2. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:533-538.
3. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain. 2000;16:205-208.
4. Cleeland CS, Syrjala KL. How to assess cancer pain. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York, NY: Guifford Publications; 1992:362-387.
5. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
7. McNair DM, Lorr M, Droppleman LF. Profile of Mood States: Manual. San Diego, Calif: Educational and Industrial Testing Service; 1981.
8. Roden DM. Antiarrhythmic drugs. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill Co; 2001:933-970.
9. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
10. Rowbotham MC, Petersen KL, Fields HL. Is postherpetic neuralgia more than one disorder? Pain Forum. 1998;7:231-237.
11. Gammaitoni AR, Davis MW, Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother. 2002;36:236-240.